Business Recitals. Buyer Introduction Buyer Indemnitee 9.2(a) Buyer Net Working Capital Statement 2.5(a) Buyer’s Benefit Plans 6.5(c) Buyer’s Pension Plans 6.5(c) Cash Payment 2.4(c) Casualty 10.2 Casualty Amount 10.2 City Certification 6.14(c) Claims Notice 9.4(a) Closing 3.1 Closing Purchase Price Reconciliation 2.5(d) Closing Statement 2.4(a) COBRA 4.13(i) Confidential Information 6.11(c) Covenant Period 6.11(a) Creative Electric Introduction Defect Notice 6.14(c) Disapproved Encumbrances 6.14(c) Disclosure Schedules Article 4 Dispute Notice 9.4(a) Employee Plans 4.13(a) Endorsements 6.14(a) ERISA Affiliate 4.13(h) Escrow Account 9.4(a) Escrow Agreement 3.2(f) Escrow Reserve Amount 2.4(d) Estimated Net Working Capital 2.4(a) Exchange Act 6.10(a) Expert Calculations 2.5(b)(iv) Final Net Working Capital Adjustment 2.5(b)(iv) Fundamental Representations 9.1(b) IDT Patents 1.1(v) Indemnified Party 9.4(a) Indemnifying Party 9.4(a) IP Cross-License Agreement 3.2(i) Lease 4.27(f) Liability Claim 9.4(a) Major Customer 4.18(a) Major Supplier 4.18(a) Micro Networks Introduction MNC Worcester Introduction Non-Assignable Contracts 3.4 party, parties Introduction Patent Assignment 3.2(b) Pension Plans 4.13(a) Permitted Title Encumbrances 6.14(a) Pre-Closing Period 6.1 Preliminary Net Working Capital Adjustment 2.4(a) Product Liability Claims 6.13(b)
(a) Purchased Tangible Personal Property 1.1(zz) Required Consents and Filings 6.2 Restricted Activity 6.11(a) Retained Liabilities 2.2 Retained Records 1.1(v) Review Period 2.5(b)(ii) Seller(s) Introduction Seller Indemnitee 9.2(b) Spectrum Introduction Stockholder Introduction Straddle Period Real Property Charges 2.6(b) Supply Agreement 3.2(h) Survey 6.14(b) Survival Period 9.1 Tangible Personal Property List 4.8 Third Party Claim 9.4(c) Title Commitment 6.14(a) Title Company 6.14(a) Title Policy 6.14(a) Trademark Assignment 3.2(c) Transferred Employees 6.5(b) Transferred Permits 1.1(zz) Transition Services Agreement 3.2(g) WARN Act 6.5(d)(ii) Warranty Obligations 6.13(a) Welfare Plans 4.13(a) Worcester Leasehold Improvements 1.1(v) Working Capital Dispute Notice 2.5(b)(ii)
Business Recitals. Buyer Preamble Buyer Indemnitee Section 6.01 Buyer’s Common Stock Section 1.04 Closing Section 2.01 Closing Date Section 2.01 CM Section 1.03 CM License Section 1.03 CM’s Transaction Shares Section 1.04 Confidentiality Agreement Section 5.01 Contracts Section 1.02(b) Control Section 1.03 Direct Claim Section 6.03(b) Disclosure Schedules Section 1.01(d) Encumbrance Section 3.07 Escrow Agent Section 2.02(b) Escrow Agreement Section 2.02(b) Escrow Shares Section 2.02(b) Excluded Assets Section 1.02 Financial Statements Section 3.04 Governmental Authority Section 1.01(h) Governmental Order Section 3.03 Indemnified Party Section 6.03(a) Indemnifying Party Section 6.03(a) Intellectual Property Agreements Section 3.09 Intellectual Property Assets Section 1.01(c) Intellectual Property Registrations Section 3.09 Inventory Section 1.01(b) Law Section 3.03 Liabilities Section 1.03 Losses Section 6.01 Material Adverse Effect Section 3.03 Members Preamble Membership Interests Section 3.02 Nasdaq Section 2.02(b)(ii) Permits Section 3.12(b) Person Section 3.03 Purchased Assets Section 1.01 Purchase Price Section 1.04 Purchased Websites Section 5.06 Securities Act Section 1.06 Seller Preamble Seller’s CM Liabilities Section 1.03 Selling Parties Preamble Selling Parties’ Authorized Agent Section 7.14 Seller Indemnitee Section 6.02 Tangible Personal Property Section 1.01(c) Taxes Section 3.13(b) Tax Returns Section 1.05 Third Party Claim Section 6.03 Transaction Documents Section 2.02(a)(ii) Pursuant to that certain Asset Purchase Agreement (the “Purchase Agreement”), dated as of even date herewith, by and among Quantitative Medicine LLC, a Delaware limited liability company (“Seller”), the members of Seller (collectively, the “Members” and jointly and severally with Seller, the “Selling Parties”), and Predictive Oncology, Inc., a Delaware corporation (“Buyer”), for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged:
Business Recitals. Cash Collateral 2.1(b)(xviii) Closing 4.1 Closing Date 4.1 Collective Bargaining Agreement 5.11(a) Company Preamble Competing Transaction 7.1 Confidentiality Agreement 8.7 Deposit Amount 3.2 Designated Purchaser 12.10 Equipment and Fixed Assets 2.1(b)(iii) Excess NWC Payment 3.3 Excluded Assets 2.2 Excluded Liabilities 2.4 FASB 410 5.13 Final Allocation Statement 10.2(a) Guarantor Preamble Interim Period 8.5(c) Mining Financial Assurances 5.13 Necessary Consent 2.6(a)
Business Recitals. Buyer Indemnified Parties 9.1 Buyer’s 401(k) Plan 3.17(f) COBRA 3.17(e) COMSEC Material 3.6 CPR 10.4 Disclosure Schedule Change 3.3(b) Dispute 10.1 DOJ 3.9(a)(i) Environmental Claim 4.18(a)(i) Environmental Hazardous Materials 4.18(a)(ii) Environmental Laws 4.18(a)(iii) Environmental Permits 4.18(a)(iv) Environmental Release 4.18(a)(v) Estimated Closing Date Balance Sheet 2.1(c) Estimated Closing Date Working Capital 2.1(c) FAR 4.23(b) FIN 48 1.59 Fincantieri Preamble FTC 3.9(a)(i) Indemnifiable Loss 9.3(i) Indemnity Claim Notice 9.3(b) Independent Accountant 2.3 International Trade Laws and Regulations 4.17(d)(i) ITAR 4.17(c) LCS 4.6(d) Lease 4.12(b)(i) Leased Real Property 1.57 MMG Benefit Plan 4.15(a) Owned Real Property 1.58 Parent Preamble Parent’s Refunds 3.14(c) Products 4.25 Protected Person 3.12(a) Purchase Price 2.1(b) Replacement 10.6(g) Request 10.4 Resigning Directors and Officers 3.10 Restricted Period 3.12(a) Seller Preamble Seller Benefit Plan 4.15(a) Seller Employee 3.17(b) Seller Indemnifiable Breach 9.3(g)(i)(B) Seller Indemnified Parties 9.2 Seller’s 401(k) Plans 3.17(f) Straddle Period 3.14(a)(iii) Tax Matter 3.14(b)(ii) Termination Fee 11.2(b) Third Party Claim 9.3(b) Third Party Consents 3.11 WARN 4.16(b) Working Capital Certificate 2.2(a)
Business Recitals. Buyer Caption Buyer Indemnitees Section 9.2(a) Buyer Parties Section 5.6 Closing Section 2.3 Closing Balance Sheet Section 2.6(b) Closing Date Section 2.3 Closing Net Working Capital Section 2.6(a)(iv) Closing Net Working Capital Statement Section 2.6(b) Closing Purchase Price Section 2.2 Covered Persons Section 6.3 Current Balance Sheet Section 3.5 D & O insurance Section 6.3(b) D & O Tail Coverage Section 6.3(b) Deductible Section 9.2(b) Directed Closing Purchase Price Section 2.4(a) Effect Section 1.1(a) Escrow Account Section 2.4(a) Escrow Agent Section 2.4(a) Escrow Agreement Section 2.4(a) Financial Statements Section 3.5 First Delayed Release Amount Section 2.7(b) First Scheduled Release Date Section 2.7(b) former D’s & O’s Section 6.3(b) GLS Interest Section 3.4 Indemnified Party Section 9.6(a) Indemnifying Party Section 9.6(a) Independent Firm Section 2.6(d) Initial Escrow Amount Section 2.4(a) Interim Financial Statements Section 3.5 Labor and Employment Matters Section 3.18(b) Leased Premises Section 3.8 Leases Section 3.8 Losses Section 9.2(a) Material Contract Section 3.13
Business Recitals. Buyer Recitals
Business Recitals. Chosen Courts Section 9.8(b)
Business Recitals. Business Day 1.1 Buyer Preamble Buyer Indemnified Parties 7.2 Buyer Indirect Parent 1.1 Cap 7.4(a) Claim 1.1 Claim Notice 7.8(a) Closing 3.2(a) Closing Data Spreadsheet 1.1 Closing Date 1.1 Closing Net Funds Employed 1.1
Business Recitals. Business Day 9.16 Client Contract 1.2(c)(i) Client Data 3.21 Closing 6.1 Closing Date 6.1 Code 2.6 Company (ies) Preamble Company Ancillary Documents 3.2(b) Company Benefit Plan 9.16 Company Contracts 3.11(a) Company Indemnified Parties 8.2 Company Intellectual Property 1.2(d) Company Licensed Software 3.16(c) Company Losses 8.2 Company Proprietary Software 3.16(b)
Business Recitals. Business Day Annex 1 Business Employees Annex 1 Business Intellectual Property 2.1(d)
(a) Business Permits 2.1(g) Business Registered IP 3.12(a)
